CN Stock MarketDetailed Quotes

301281 Shandong Keyuan Pharmaceutical

Watchlist
  • 22.32
  • +0.09+0.40%
Market Closed Aug 15 15:00 CST
2.42BMarket Cap36.35P/E (TTM)

Shandong Keyuan Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
17.75%146.28M
1.07%447.58M
1.86%340.68M
0.14%224.47M
9.52%124.23M
5.22%442.87M
334.44M
5.44%224.17M
113.43M
14.67%420.89M
Operating revenue
17.75%146.28M
1.07%447.58M
1.86%340.68M
0.14%224.47M
9.52%124.23M
5.22%442.87M
--334.44M
5.44%224.17M
--113.43M
14.67%420.89M
Other operating revenue
----
197.68%1.64M
----
-45.07%318.93K
----
-54.83%551.34K
----
--580.56K
----
10.01%1.22M
Total operating cost
39.64%124.46M
9.52%381.06M
6.30%276.62M
3.92%172.91M
7.52%89.13M
3.03%347.93M
260.23M
166.38M
82.9M
15.35%337.69M
Operating cost
50.02%85.6M
-9.74%236.09M
-15.40%170.83M
-20.08%106.24M
-14.67%57.06M
7.34%261.57M
--201.92M
--132.94M
--66.87M
32.93%243.69M
Operating tax surcharges
11.55%1.57M
-8.63%4.84M
0.23%3.72M
16.66%2.68M
43.29%1.4M
18.55%5.3M
--3.71M
--2.3M
--979.89K
-16.04%4.47M
Operating expense
45.21%20.93M
121.15%63.4M
159.07%45.43M
222.30%31.09M
197.31%14.41M
9.78%28.67M
--17.53M
--9.65M
--4.85M
-33.95%26.12M
Administration expense
-3.61%8.51M
33.96%37.71M
35.02%30.11M
76.90%20.46M
63.99%8.83M
-27.30%28.15M
--22.3M
--11.57M
--5.38M
13.70%38.72M
Financial expense
-35.84%-930.33K
-77.84%-4.85M
-202.22%-3.3M
-1,159.91%-3.03M
-412.41%-684.88K
-1,129.12%-2.73M
---1.09M
---240.16K
--219.22K
-90.03%264.89K
-Interest Income (Financial expense)
---1.28M
-183.42%-3.77M
-253.33%-2.94M
-277.10%-1.84M
----
-38.11%-1.33M
---831.5K
---486.98K
----
-761.27%-962.89K
Research and development
8.32%8.78M
62.64%43.86M
88.13%29.83M
52.02%15.46M
76.56%8.11M
10.39%26.97M
--15.86M
--10.17M
--4.59M
-12.27%24.43M
Credit Impairment Loss
-354.16%-1.7M
89.47%-115.01K
61.96%-659.66K
125.05%469.56K
64.98%-375.18K
-276.71%-1.09M
---1.73M
---1.87M
---1.07M
-54.44%617.94K
Asset Impairment Loss
88.05%-2.84K
-37.26%-3.38M
91.75%-97.65K
87.29%-97.65K
52.89%-23.76K
-247.00%-2.46M
---1.18M
---768.2K
---50.43K
65.27%-709.05K
Other net revenue
472.12%2.61M
319.53%13.59M
153.11%7.63M
393.93%3.07M
397.41%456.37K
-51.11%3.24M
3.01M
621.58K
91.75K
54.15%6.63M
Fair value change income
--1.02M
--543.18K
--4.23M
--432.6K
----
----
----
----
----
----
Invest income
--540.74K
--12.2M
--1.67M
--348.61K
----
----
----
----
----
----
-Including: Investment income associates
----
--3.08M
----
----
----
----
----
----
----
----
Asset deal income
----
-9.16%345.99K
-89.44%11.48K
--11.48K
----
931.22%380.88K
--108.77K
----
----
-78.55%36.94K
Other revenue
222.65%2.76M
-37.73%3.99M
-57.60%2.47M
-41.63%1.91M
-29.52%855.32K
-4.03%6.41M
--5.82M
--3.26M
--1.21M
38.85%6.68M
Operating profit
-31.29%24.43M
-18.39%80.12M
-7.17%71.69M
-6.46%54.63M
16.09%35.55M
9.29%98.17M
77.22M
26.42%58.4M
30.62M
14.26%89.82M
Add:Non operating Income
----
8.13%313.37K
-11.99%234.54K
-28.21%138.32K
-84.06%141.86K
-38.76%289.8K
--266.51K
--192.66K
--889.86K
-83.62%473.2K
Less:Non operating expense
2,102.48%1.2M
331.80%694.89K
272.55%579.51K
105.57%282.64K
548.45%54.46K
-57.35%160.93K
--155.55K
--137.49K
--8.4K
-10.30%377.31K
Total profit
-34.82%23.23M
-18.89%79.74M
-7.75%71.34M
-6.79%54.49M
13.12%35.64M
9.32%98.3M
77.33M
26.42%58.46M
31.51M
10.90%89.92M
Less:Income tax cost
-51.97%1.71M
-61.61%2.7M
-43.46%4.79M
-55.59%3.28M
-12.50%3.55M
-40.22%7.02M
--8.47M
--7.39M
--4.06M
-5.51%11.75M
Net profit
-32.92%21.52M
-15.60%77.04M
-3.36%66.55M
0.27%51.2M
16.91%32.09M
16.77%91.28M
68.87M
27.95%51.07M
27.45M
13.87%78.17M
Net profit from continuing operation
-32.92%21.52M
-15.60%77.04M
-3.36%66.55M
0.27%51.2M
16.91%32.09M
16.77%91.28M
--68.87M
--51.07M
--27.45M
13.87%78.17M
Less:Minority Profit
---8.77K
----
----
----
----
----
----
----
----
----
Net profit of parent company owners
-32.90%21.53M
-15.60%77.04M
-3.36%66.55M
0.27%51.2M
16.91%32.09M
16.77%91.28M
--68.87M
27.95%51.07M
--27.45M
13.87%78.17M
Earning per share
Basic earning per share
-64.07%0.1988
-32.14%0.76
-20.94%0.6705
-14.07%0.5404
17.72%0.5533
-17.04%1.12
--0.8481
--0.6289
--0.47
14.41%1.35
Diluted earning per share
-64.07%0.1988
-32.14%0.76
-20.94%0.6705
-14.07%0.5404
17.72%0.5533
-17.04%1.12
--0.8481
--0.6289
--0.47
14.41%1.35
Other composite income
Total composite income
-32.92%21.52M
-15.60%77.04M
-3.36%66.55M
0.27%51.2M
16.91%32.09M
16.77%91.28M
68.87M
51.07M
27.45M
13.87%78.17M
Total composite income of parent company owners
-32.90%21.53M
-15.60%77.04M
-3.36%66.55M
0.27%51.2M
16.91%32.09M
16.77%91.28M
--68.87M
--51.07M
--27.45M
13.87%78.17M
Total composite income of minority owners
---8.77K
----
----
----
----
----
----
----
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 17.75%146.28M1.07%447.58M1.86%340.68M0.14%224.47M9.52%124.23M5.22%442.87M334.44M5.44%224.17M113.43M14.67%420.89M
Operating revenue 17.75%146.28M1.07%447.58M1.86%340.68M0.14%224.47M9.52%124.23M5.22%442.87M--334.44M5.44%224.17M--113.43M14.67%420.89M
Other operating revenue ----197.68%1.64M-----45.07%318.93K-----54.83%551.34K------580.56K----10.01%1.22M
Total operating cost 39.64%124.46M9.52%381.06M6.30%276.62M3.92%172.91M7.52%89.13M3.03%347.93M260.23M166.38M82.9M15.35%337.69M
Operating cost 50.02%85.6M-9.74%236.09M-15.40%170.83M-20.08%106.24M-14.67%57.06M7.34%261.57M--201.92M--132.94M--66.87M32.93%243.69M
Operating tax surcharges 11.55%1.57M-8.63%4.84M0.23%3.72M16.66%2.68M43.29%1.4M18.55%5.3M--3.71M--2.3M--979.89K-16.04%4.47M
Operating expense 45.21%20.93M121.15%63.4M159.07%45.43M222.30%31.09M197.31%14.41M9.78%28.67M--17.53M--9.65M--4.85M-33.95%26.12M
Administration expense -3.61%8.51M33.96%37.71M35.02%30.11M76.90%20.46M63.99%8.83M-27.30%28.15M--22.3M--11.57M--5.38M13.70%38.72M
Financial expense -35.84%-930.33K-77.84%-4.85M-202.22%-3.3M-1,159.91%-3.03M-412.41%-684.88K-1,129.12%-2.73M---1.09M---240.16K--219.22K-90.03%264.89K
-Interest Income (Financial expense) ---1.28M-183.42%-3.77M-253.33%-2.94M-277.10%-1.84M-----38.11%-1.33M---831.5K---486.98K-----761.27%-962.89K
Research and development 8.32%8.78M62.64%43.86M88.13%29.83M52.02%15.46M76.56%8.11M10.39%26.97M--15.86M--10.17M--4.59M-12.27%24.43M
Credit Impairment Loss -354.16%-1.7M89.47%-115.01K61.96%-659.66K125.05%469.56K64.98%-375.18K-276.71%-1.09M---1.73M---1.87M---1.07M-54.44%617.94K
Asset Impairment Loss 88.05%-2.84K-37.26%-3.38M91.75%-97.65K87.29%-97.65K52.89%-23.76K-247.00%-2.46M---1.18M---768.2K---50.43K65.27%-709.05K
Other net revenue 472.12%2.61M319.53%13.59M153.11%7.63M393.93%3.07M397.41%456.37K-51.11%3.24M3.01M621.58K91.75K54.15%6.63M
Fair value change income --1.02M--543.18K--4.23M--432.6K------------------------
Invest income --540.74K--12.2M--1.67M--348.61K------------------------
-Including: Investment income associates ------3.08M--------------------------------
Asset deal income -----9.16%345.99K-89.44%11.48K--11.48K----931.22%380.88K--108.77K---------78.55%36.94K
Other revenue 222.65%2.76M-37.73%3.99M-57.60%2.47M-41.63%1.91M-29.52%855.32K-4.03%6.41M--5.82M--3.26M--1.21M38.85%6.68M
Operating profit -31.29%24.43M-18.39%80.12M-7.17%71.69M-6.46%54.63M16.09%35.55M9.29%98.17M77.22M26.42%58.4M30.62M14.26%89.82M
Add:Non operating Income ----8.13%313.37K-11.99%234.54K-28.21%138.32K-84.06%141.86K-38.76%289.8K--266.51K--192.66K--889.86K-83.62%473.2K
Less:Non operating expense 2,102.48%1.2M331.80%694.89K272.55%579.51K105.57%282.64K548.45%54.46K-57.35%160.93K--155.55K--137.49K--8.4K-10.30%377.31K
Total profit -34.82%23.23M-18.89%79.74M-7.75%71.34M-6.79%54.49M13.12%35.64M9.32%98.3M77.33M26.42%58.46M31.51M10.90%89.92M
Less:Income tax cost -51.97%1.71M-61.61%2.7M-43.46%4.79M-55.59%3.28M-12.50%3.55M-40.22%7.02M--8.47M--7.39M--4.06M-5.51%11.75M
Net profit -32.92%21.52M-15.60%77.04M-3.36%66.55M0.27%51.2M16.91%32.09M16.77%91.28M68.87M27.95%51.07M27.45M13.87%78.17M
Net profit from continuing operation -32.92%21.52M-15.60%77.04M-3.36%66.55M0.27%51.2M16.91%32.09M16.77%91.28M--68.87M--51.07M--27.45M13.87%78.17M
Less:Minority Profit ---8.77K------------------------------------
Net profit of parent company owners -32.90%21.53M-15.60%77.04M-3.36%66.55M0.27%51.2M16.91%32.09M16.77%91.28M--68.87M27.95%51.07M--27.45M13.87%78.17M
Earning per share
Basic earning per share -64.07%0.1988-32.14%0.76-20.94%0.6705-14.07%0.540417.72%0.5533-17.04%1.12--0.8481--0.6289--0.4714.41%1.35
Diluted earning per share -64.07%0.1988-32.14%0.76-20.94%0.6705-14.07%0.540417.72%0.5533-17.04%1.12--0.8481--0.6289--0.4714.41%1.35
Other composite income
Total composite income -32.92%21.52M-15.60%77.04M-3.36%66.55M0.27%51.2M16.91%32.09M16.77%91.28M68.87M51.07M27.45M13.87%78.17M
Total composite income of parent company owners -32.90%21.53M-15.60%77.04M-3.36%66.55M0.27%51.2M16.91%32.09M16.77%91.28M--68.87M--51.07M--27.45M13.87%78.17M
Total composite income of minority owners ---8.77K------------------------------------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg